Home/Pipeline/Paroxetine HCl Extended Release Tablets

Paroxetine HCl Extended Release Tablets

Depression, Anxiety Disorders

ApprovedActive

Key Facts

Indication
Depression, Anxiety Disorders
Phase
Approved
Status
Active
Company

About Sciecure Pharma

Sciecure Pharma is a private, commercial-stage generic drug company that has successfully navigated the FDA approval pathway for at least two products since its founding in 2015. The company operates in the highly competitive but essential generic pharmaceuticals sector, aiming to offer lower-cost alternatives to branded medications. Its approved products include a generic version of Paroxetine HCl Extended Release tablets and Budesonide capsules, indicating a focus on central nervous system and gastrointestinal/inflammatory conditions. As a small, private entity, its growth will depend on its ability to expand its portfolio through additional ANDA filings and approvals.

View full company profile